AIDS
-
Multicenter Study
Interim fluoro-2-deoxy-D-glucose-PET predicts response and progression-free survival in patients with Hodgkin lymphoma and HIV infection.
Interim PET scans in HIV-negative patients with Hodgkin lymphoma has emerged as one of the most important prognostic tools. However, equivalent studies in HIV-positive patients are yet to be performed. ⋯ A negative interim 18F-FDG PET result is highly predictive of treatment success in HIV-HL patients.